NCT07235098 Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery
| NCT ID | NCT07235098 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oncology Institute of Southern Switzerland |
| Condition | Lung Cancer (Suspected or Confirmed) |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2026-06-19 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2026-06-19 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims at evaluating whether music therapy intervention is effective in decreasing psychological (distress) and physical symptoms (pain) in patients with suspected or diagnosed lung cancer undergoing minimally invasive lung surgery.
Eligibility Criteria
Inclusion Criteria: * Suspected or confirmed diagnosis of lung cancer * Age ≥ 18 years * Indication for lung resection through a minimally invasive surgery * Signed written informed consent Exclusion Criteria: * Endocrinological disorders involving cortisol axis * Chronic steroid intake \> 10 mg/day * Concomitant treatment with drugs against symptomatic anxiety and/or depression * Partial or complete hearing loss * Inability to follow the schedule of investigation * Patient unwilling to refrain from actively listening to other music (e.g., via other personal devices/headphones) outside of the prescribed musical intervention defined by the study protocol during the hospitalization.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07235098 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer (Suspected or Confirmed). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07235098 currently recruiting?
Yes, NCT07235098 is actively recruiting participants. Contact the research team at patrizia.froesch@eoc.ch for enrollment information.
Where is the NCT07235098 trial being conducted?
This trial is being conducted at Bellinzona, Switzerland.
Who is sponsoring the NCT07235098 clinical trial?
NCT07235098 is sponsored by Oncology Institute of Southern Switzerland. The trial plans to enroll 74 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.